# Garrett M. Frampton

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/garrett-m-frampton/

## Facts

| Field | Value |
| --- | --- |
| Citations | 44,490 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 86 |
| i10-index | 180 |
| Last Known Institution | Boston Foundation |
| OpenAlex ID | https://openalex.org/A5071731260 |
| ORCID iD | 0000-0002-2361-2750 |
| Works | 674 |

## Researcher papers

Showing 12 of 22.

- [Histone H3K27ac separates active from poised enhancers and predicts developmental state](https://scholariq.org/papers/histone-h3k27ac-separates-active-from-poised-enhancers-and-predicts/)
- [Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden](https://scholariq.org/papers/analysis-of-100-000-human-cancer-genomes-reveals-the-landscape-of-tumor/)
- [Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial](https://scholariq.org/papers/atezolizumab-in-patients-with-locally-advanced-and-metastatic-urothelial/)
- [Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers](https://scholariq.org/papers/tumor-mutational-burden-as-an-independent-predictor-of-response-to-immunotherapy/)
- [Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing](https://scholariq.org/papers/development-and-validation-of-a-clinical-cancer-genomic-profiling-test-based-on/)
- [<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/i-stk11-lkb1-i-mutations-and-pd-1-inhibitor-resistance-in-i-kras-i-mutant-lung/)
- [Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells](https://scholariq.org/papers/connecting-microrna-genes-to-the-core-transcriptional-regulatory-circuitry-of/)
- [Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis](https://scholariq.org/papers/densely-interconnected-transcriptional-circuits-control-cell-states-in-human/)
- [Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities](https://scholariq.org/papers/co-occurring-genomic-alterations-define-major-subsets-of-i-kras-i-mutant-lung/)
- [Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies](https://scholariq.org/papers/identification-of-new-alk-and-ret-gene-fusions-from-colorectal-and-lung-cancer/)
- [Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors](https://scholariq.org/papers/activation-of-met-via-diverse-exon-14-splicing-alterations-occurs-in-multiple/)
- [Mechanisms and therapeutic implications of hypermutation in gliomas](https://scholariq.org/papers/mechanisms-and-therapeutic-implications-of-hypermutation-in-gliomas/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)

## Researcher university

- [Boston Foundation](https://scholariq.org/institutions/boston-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.